I 
113TH CONGRESS 
2D SESSION 
H. R. 4472 
To provide for the establishment of a grant program to support United 
States-Israeli cooperation for neuroscience-related research, and for other 
purposes. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 10, 2014 
Mr. FATTAH introduced the following bill; which was referred to the 
Committee on Energy and Commerce 
A BILL 
To provide for the establishment of a grant program to 
support United States-Israeli cooperation for neuro-
science-related research, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘US–Israel Global Neu-
roscience Partnership Act of 2014’’. 
SEC. 2. FINDINGS. 
Congress finds that— 
VerDate Mar 15 2010 
00:22 Apr 16, 2014
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4472.IH
H4472
jbell on DSK7SPTVN1PROD with BILLS
(1) it is in the highest national security inter-
ests of the United States to develop neuroscience-re-
lated research and neurotechnology; 
(2) the State of Israel is a steadfast ally of the 
United States; 
(3) the special relationship between the United 
States and Israel is manifested in a variety of coop-
erative scientific research and development pro-
grams, such as— 
(A) the United States-Israel Binational 
Science Foundation; and 
(B) the United States-Israel Binational In-
dustrial Research and Development Founda-
tion; 
(4) those programs have made possible many 
scientific, technological, and commercial break-
throughs in the fields of life sciences, medicine, bio-
engineering, agriculture, biotechnology, communica-
tions, and others; 
(5) in December 2011 the Office of Science and 
Technology Policy was directed by Congress to es-
tablish an Interagency Working Group on Neuro-
science which was chartered on June 20, 2012, is 
housed at the White House, and is currently con-
vening representatives across the Federal Govern-
VerDate Mar 15 2010 
00:22 Apr 16, 2014
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4472.IH
H4472
jbell on DSK7SPTVN1PROD with BILLS
ment to make recommendations about the future of 
neuroscience research; 
(6) Israeli scientists and engineers are at the 
forefront of research and development in the field of 
neuroscience; 
(7) Israel Brain Technologies is a nonprofit or-
ganization whose mission is to turn Israel into a 
global brain technology and research leader by— 
(A) supporting applied brain research; 
(B) accelerating brain technology develop-
ment; 
(C) creating and fostering a community 
around neurotechnology; and 
(D) attracting key stakeholders to partner 
and support brain technology in Israel; and 
(8) enhanced cooperation between the United 
States and Israel for the purpose of research and de-
velopment of neuroscience would be in the national 
interests of both countries. 
SEC. 3. GRANTS FOR NEUROSCIENCE-RELATED RESEARCH. 
(a) AUTHORITY.—The Secretary, acting through the 
Director of the National Institutes of Health, in consulta-
tion with the BIRD or BSF, shall award grants to eligible 
entities for neuroscience-related research. 
(b) APPLICATION.— 
VerDate Mar 15 2010 
00:22 Apr 16, 2014
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H4472.IH
H4472
jbell on DSK7SPTVN1PROD with BILLS
(1) SUBMISSION OF APPLICATIONS.—To receive 
a grant under this section, an eligible entity shall 
submit an application to the Secretary containing 
such information and assurances as the Secretary, in 
consultation with the BIRD or BSF, may require. 
(2) SELECTION OF ELIGIBLE ENTITIES.—The 
Secretary, in consultation with the Directors of the 
BIRD and BSF, may review any application sub-
mitted by any eligible entity and select any eligible 
entity meeting criteria established by the Secretary, 
in consultation with the Advisory Board, for a grant 
under this section. 
(c) AMOUNT OF GRANT.—The amount of each grant 
awarded for a fiscal year under this section shall be deter-
mined by the Secretary, in consultation with the BIRD 
or BSF. 
(d) RECOUPMENT.— 
(1) IN
GENERAL.—Not later than 180 days 
after the date of enactment of this Act, the Sec-
retary shall establish procedures and criteria for 
recoupment in connection with any eligible project 
carried out by an eligible entity that receives a grant 
under this section, which has led to the development 
of a product or process which is marketed or used. 
(2) AMOUNT REQUIRED.— 
VerDate Mar 15 2010 
00:22 Apr 16, 2014
Jkt 039200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H4472.IH
H4472
jbell on DSK7SPTVN1PROD with BILLS
(A) Except as provided in subparagraph 
(B), such recoupment shall be required as a 
condition for award and be proportional to the 
Federal share of the costs of such project, and 
shall be derived from the proceeds of royalties 
or licensing fees received in connection with 
such product or process. 
(B) In the case where a product or process 
is used by the recipient of a grant under this 
section for the production and sale of its own 
products or processes, the recoupment shall 
consist of a payment equivalent to the payment 
which would be made under subparagraph (A). 
(3) WAIVER.—The Secretary may at any time 
waive or defer all or some of the recoupment re-
quirements of this subsection as necessary, depend-
ing on— 
(A) the commercial competitiveness of the 
entity or entities developing or using the prod-
uct or process; 
(B) the profitability of the project; and 
(C) the commercial viability of the product 
or process utilized. 
VerDate Mar 15 2010 
00:22 Apr 16, 2014
Jkt 039200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H4472.IH
H4472
jbell on DSK7SPTVN1PROD with BILLS
(e) PRIVATE FUNDS.—The Secretary may accept 
contributions of funds from private sources to carry out 
this Act. 
(f) REPORT.—Not later than 180 days after receiving 
a grant under this section, each recipient shall submit a 
report to the Secretary— 
(1) documenting how the recipient used the 
grant funds; and 
(2) evaluating the level of success of each 
project funded by the grant. 
SEC. 4. INTERNATIONAL NEUROSCIENCE-RELATED RE-
SEARCH ADVISORY BOARD. 
(a) ESTABLISHMENT.—There is established in the 
National Institutes of Health an International Neuro-
science-Related Research Advisory Board. 
(b) DUTIES.—The Advisory Board shall advise the 
Secretary on— 
(1) criteria for the recipients of grants awarded 
under section 3(a); 
(2) the total amount of grant money to be 
awarded to all grantees selected by the Secretary, in 
consultation with the BIRD; and 
(3) the total amount of grant money to be 
awarded to all grantees selected by the Secretary, in 
consultation with the BSF, for each fiscal year. 
VerDate Mar 15 2010 
00:22 Apr 16, 2014
Jkt 039200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H4472.IH
H4472
jbell on DSK7SPTVN1PROD with BILLS
(c) MEMBERSHIP.— 
(1) COMPOSITION.—The Advisory Board shall 
be composed of— 
(A) 1 member appointed by the Director of 
the National Science Foundation; 
(B) 1 member appointed by the Director of 
the National Institutes of Health; 
(C) 1 member appointed by the Director of 
the National Institute of Standards and Tech-
nology; and 
(D) in addition to the member appointed 
under subparagraph (B), 3 members who shall 
be Israeli citizens, appointed by the Director of 
the National Institutes of Health after con-
sultation with appropriate officials in the Israeli 
Government. 
(2) DEADLINE FOR APPOINTMENTS.—The ini-
tial appointments under paragraph (1) shall be 
made not later than 60 days after the date of enact-
ment of this Act. 
(3) TERM.—Each member of the Advisory 
Board shall be appointed for a term of 4 years. 
(4) VACANCIES.—A vacancy on the Advisory 
Board shall be filled in the manner in which the 
original appointment was made. 
VerDate Mar 15 2010 
00:22 Apr 16, 2014
Jkt 039200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H4472.IH
H4472
jbell on DSK7SPTVN1PROD with BILLS
(5) BASIC PAY.— 
(A) COMPENSATION.—A member of the 
Advisory Board shall serve without pay. 
(B) TRAVEL EXPENSES.—Each member of 
the Advisory Board shall receive travel ex-
penses, including per diem in lieu of subsist-
ence, in accordance with applicable provisions of 
subchapter I of chapter 57 of title 5, United 
States Code. 
(6) QUORUM.—Three members of the Advisory 
Board shall constitute a quorum. 
(7) CHAIRPERSON.—The Chairperson of the 
Advisory Board shall be designated by the Director 
of the National Institutes of Health from among the 
members appointed by the Director at the time of 
the appointment. 
(8) MEETINGS.—The Advisory Board shall 
meet at least once annually at the call of the Chair-
person. 
(d) TERMINATION.—Section 14(a)(2)(B) of the Fed-
eral Advisory Committee Act (5 U.S.C. App.) shall not 
apply to the Advisory Board. 
SEC. 5. DEFINITIONS. 
In this Act: 
VerDate Mar 15 2010 
00:22 Apr 16, 2014
Jkt 039200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H4472.IH
H4472
jbell on DSK7SPTVN1PROD with BILLS
(1) ADVISORY
BOARD.—The term ‘‘Advisory 
Board’’ means the International Neuroscience-Re-
lated Research Advisory Board established by sec-
tion 4(a). 
(2) BIRD.—The term ‘‘BIRD’’ means the 
Israel-United States Binational Industrial Research 
and Development Foundation. 
(3) BSF.—The term ‘‘BSF’’ means the United 
States-Israel Binational Science Foundation. 
(4) ELIGIBLE ENTITY.—The term ‘‘eligible enti-
ty’’ means a joint venture comprised of both Israeli 
and United States private business entities or a joint 
venture comprised of both Israeli academic persons 
(who reside and work in Israel) and United States 
academic persons, that— 
(A) carries out an eligible project; and 
(B) is selected by the Secretary, in con-
sultation with the BIRD or BSF, using the cri-
teria established by the Secretary, in consulta-
tion with the Advisory Board. 
(5) ELIGIBLE
PROJECT.—The term ‘‘eligible 
project’’ means a project to encourage cooperation 
between the United States and Israel on neuro-
science-related research. 
VerDate Mar 15 2010 
00:22 Apr 16, 2014
Jkt 039200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H4472.IH
H4472
jbell on DSK7SPTVN1PROD with BILLS
(6) SECRETARY.—The term ‘‘Secretary’’ means 
the Secretary of Health and Human Services. 
SEC. 6. TERMINATION. 
The grant program authorized under section 3 and 
the Advisory Board shall terminate upon the expiration 
of the 7-year period which begins on the date of the enact-
ment of this Act. 
SEC. 7. AUTHORIZATION OF APPROPRIATIONS. 
The Secretary is authorized to expend not more than 
$20,000,000 to carry out this Act for each of fiscal years 
2014 through 2020. 
Æ 
VerDate Mar 15 2010 
00:22 Apr 16, 2014
Jkt 039200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6301
E:\BILLS\H4472.IH
H4472
jbell on DSK7SPTVN1PROD with BILLS